Monitor the Q3 Fiscal 2026 earnings release around August 11 for the first consolidated financials including Sanity — revenue contribution and margin profile will be key. The sequential market share improvement in June is a positive signal, but the YoY decline in overall share warrants caution. The September investor session may provide longer-term strategic clarity.
Price Chart
Executive Summary
Organigram provided a business update highlighting Sanity Group's initial performance in line with expectations (~10% German market share) and Canadian market share trends. Overall Canadian recreational share was 11.1% at June end, down 0.4pp YoY but up 100bps sequentially from May, with sequential improvements in vape and pre-roll categories. No financial figures were disclosed; Q3 Fiscal 2026 consolidated results (first including Sanity) are expected around August 11, 2026.
Key Facts
- Sanity acquisition closed April 15, 2026; Sanity holds ~10% German medical cannabis market share, performing in line with revenue expectations.
- German reimbursement regulatory changes not material — reimbursement sales are ~1% of Sanity's total revenue.
- Canadian recreational market share at June end: 11.1% overall, down 0.4pp YoY but up 100bps sequentially vs May.
- Organigram holds #1 positions in Flower (12.5% share) and Vapes (14.5% share), and #2 in Pre-rolls (7.3% share).
- Sequential market share improvements in vape and pre-roll categories during June after Q2 declines.
- Q3 Fiscal 2026 results expected on or about August 11, 2026 — first consolidated quarter including Sanity.
- Digital Investor Session planned for late September 2026 for strategic update post-Sanity acquisition.
Financial Impact
No financial figures disclosed; operational metrics only (market share percentages).
Risk Factors
- German regulatory changes on cannabis reimbursement could expand beyond current immaterial impact.
- Canadian market share erosion (down 0.4pp YoY) may continue if competitive pressures intensify.
- Sanity integration and international expansion execution risk; no financial data yet to validate performance.
- Forward-looking statements with no hard financials — stock may be volatile on sentiment alone.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001628280-26-048830 |
| Document: form6-kxjuly202026.htm | 0001628280-26-048830 |
| Document: 0001628280-26-048830-index-headers.html | 0001628280-26-048830 |
| Document: 0001628280-26-048830-index.html | 0001628280-26-048830 |
| Document: 0001628280-26-048830.txt | 0001628280-26-048830 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | 6-K | $0.9316 | awaiting T+60 | — | $0.9390 (+0.79%) |
Sep 3, 2026 7w ago | 6-K | $1.17 | awaiting T+60 | — | $0.9390 (−19.74%) |
Aug 20, 2026 9w ago | 6-K | $1.20 | awaiting T+60 | — | $0.9390 (−21.75%) |
Aug 11, 2026 10w ago | 6-K | $1.23 | awaiting T+60 | — | $0.9390 (−23.66%) |
Aug 4, 2026 11w ago | 6-K | $0.9930 | awaiting T+60 | — | $0.9390 (−5.44%) |
Jul 20, 2026 14w ago | 6-K | $0.9448 $0.9190 | ▼ −2.73% | ▼ −6.70% | $0.9390 (−0.61%) |
Jun 11, 2026 19w ago | Institutional Cluster | $1.08 $1.16 | ▲ +6.94% | ▲ +2.55% | $0.9390 (−13.06%) |
May 6, 2026 24w ago | 6-K | $1.39 $0.9393 | ▼ −32.42% | ▼ −34.49% | $0.9390 (−32.45%) |
Mar 30, 2026 30w ago | 6-K | $1.34 $1.03 | ▼ −23.13% | ▼ −35.52% | $0.9390 (−29.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers